Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
Plasmacytoid dendritic cells (pDCs) sense viral and microbial DNA through endosomal Toll-like receptors to produce type 1 interferons. pDCs do not normally respond to self-DNA, but this restriction seems to break down in human autoimmune disease by an as yet poorly understood mechanism. Here we identify the antimicrobial peptide LL37 (also known as CAMP) as the key factor that mediates pDC activation in psoriasis, a common autoimmune disease of the skin. LL37 converts inert self-DNA into a potent trigger of interferon production by binding the DNA to form aggregated and condensed structures that are delivered to and retained within early endocytic compartments in pDCs to trigger Toll-like receptor 9. Thus, our data uncover a fundamental role of an endogenous antimicrobial peptide in breaking innate tolerance to self-DNA and suggest that this pathway may drive autoimmunity in psoriasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the anti-microbial peptide LL37 has been shown to promote trafficking of aggregated DNA structures to the early endosome, promoting TLR9 activation and interferon production (Lande et al., 2007)”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Lande et al., 2007
In the citing paper
“Interestingly, suction blister wounds, where the blister roof is still intact, do not show substantial inflammation,9 whereas excisional wounds, ultraviolet (UV)-induced skin damage, superficial tape stripping or chemical skin irritants, and contact sensitizers cause inflammatory infiltrates,17,23–26”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [23]
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,245
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Self-citationEndogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960
Pathogenesis and therapy of psoriasis
Lowes, M. A., Bowcock, A. M., & Krueger, J. G. (2007) · Nature · doi:10.1038/nature05663 · Cited by 1,778
Plasmacytoid dendritic cells in immunity
Colonna, M., Trinchieri, G., & Liu, Y.-J. (2004) · Nature Immunology · doi:10.1038/ni1141 · Cited by 1,678
Self-citation
Cited by
Items 401–500 of 1,000
Coorens, M., Scheenstra, M. R., Veldhuizen, E. J. A., & Haagsman, H. P. (2017) · Scientific Reports · doi:10.1038/srep40874 · Cited by 105
Molecular and Structural Basis of DNA Sensors in Antiviral Innate Immunity
Zahid, A., Ismail, H., Li, B., & Jin, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613039 · Cited by 100
“Based on current knowledge, the signaling specificity of DNA sensors is attributed to various factors such as (i) length, 3D structure and sequence of cytotoxic DNA (8, 69, 70); (ii) subcellular localization of DNA molecules (71); (iii) methylation status of DNA (68) and (iv) association of histones and non-histone ch…”
BackgroundDistinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus
Chan, V. S. F., Nie, Y.-J., Shen, N., Yan, S., Mok, M. Y., & Lau, C.-S. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.03.004 · Cited by 111
Psoriasis: from pathogenesis to novel therapeutic approaches
Monteleone, G., Pallone, F., MacDonald, T. T., Chimenti, S., & Costanzo, A. (2010) · Clinical Science · doi:10.1042/cs20100163 · Cited by 117
Buerger, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02786 · Cited by 291
“Currently it is assumed that sustained activation of plasmacytoid dendritic cells by epidermal antigens due to skin trauma or infection is the first step in the pathogenesis of psoriasis (3).”
BackgroundWei, X., Zhang, L., Yang, Y., Hou, Y., Xu, Y., Wang, Z., Su, H., Han, F., Han, J., Liu, P., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110880 · Cited by 106
Hing, T. C., Ho, S., Shih, D. Q., Ichikawa, R., Cheng, M., Chen, J., Chen, X., Law, I. K. M., Najarían, R. M., Kelly, C. P., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-302180 · Cited by 109
Liquid-crystalline ordering of antimicrobial peptide–DNA complexes controls TLR9 activation
Schmidt, N. W., Jin, F., Lande, R., Curk, T., Xian, W., Lee, C. K., Frasca, L., Frenkel, D., Dobnikar, J., Gilliet, M. F., et al. (2015) · Nature Materials · doi:10.1038/nmat4298 · Cited by 109
Self-citationImmunomodulation in psoriatic arthritis: Focus on cellular and molecular pathways
Chimenti, M. S., Ballanti, E., Perricone, C., Cipriani, P., Giacomelli, R., & Perricone, R. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.10.002 · Cited by 102
“It is unclear whether the interferon response pathway might central to pathogenesis or is an epiphenomenon depending on the chronic injury of tissues [25].”
BackgroundKraaij, T., Wieland, F. C., Kamerling, S. W. A., Pusey, C. D., Scherer, H. U., Toes, R. E. M., Rabelink, T. J., van Kooten, C., & Teng, Y. K. O. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.02.018 · Cited by 108
Self-dsDNA in the pathogenesis of systemic lupus erythematosus
Bai, Y., Tong, Y., Liu, Y., & Hu, H. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.13041 · Cited by 113
Self-citationPatra, V., Wagner, K., Arulampalam, V., & Wolf, P. (2019) · iScience · doi:10.1016/j.isci.2019.04.026 · Cited by 99
IL-36 Promotes Systemic IFN-I Responses in Severe Forms of Psoriasis
Catapano, M., Vergnano, M., Romano, M., Mahil, S. K., Choon, S. E., Burden, A. D., Young, H. S., Carr, I., Lachmann, H. J., Lombardi, G., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.08.444 · Cited by 113
Angelot, F., Seillès, E., Biichlé, S., Berda, Y., Gaugler, B., Plumas, J., Chaperot, L., Dignat‐George, F., Tiberghien, P., Saas, P., et al. (2009) · Haematologica · doi:10.3324/haematol.2009.010934 · Cited by 113
“23,32 Nothing is known about the capacity of EMP to activate PDC.”
BackgroundInfluentialCao, W., & Bover, L. C. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00867.x · Cited by 113
“Several host factors, including anti-DNA antibodies, anti-microbial peptide LL37, and the nuclear DNA-binding protein HMGB1, alone or in combination, facilitate entry of self-DNA into pDCs, where they trigger TLR9 to induce type I IFN (137, 139, 140).”
BackgroundSelf-citationEndothelium-Neutrophil Interactions in ANCA-Associated Diseases
Halbwachs‐Mecarelli, L., & Lesavre, P. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012020119 · Cited by 106
Zabieglo, K., Majewski, P., Majchrzak-Gorecka, M., Włodarczyk, A., Grygier, B., Zegar, A., Kapińska-Mrowiecka, M., Naskalska, A., Pyrć, K., Dubin, A., et al. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4ab1114-543r · Cited by 113
“Likewise, excessive NET formation or impaired NET degradation was associated with autoinflammatory diseases [34], and a putative link between NETs and autoimmunity has been proposed [1, 2, 36].”
BackgroundImmunity to commensal skin fungi promotes psoriasiform skin inflammation
Hurabielle, C., Link, V. M., Bouladoux, N., Han, S.-J., Merrill, E. D., Lightfoot, Y. L., Seto, N., Bleck, C. K. E., Smelkinson, M., Harrison, O. J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003022117 · Cited by 97
The role of innate immunity in the induction of autoimmunity
Pisetsky, D. S. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.07.028 · Cited by 99
“Both LL37 and HMGB1may form complexes with DNA that has been released from dead or dying cells for delivery into cells to stimulate internal receptors or TLR9 [18,19].”
BackgroundNikolic, B. B., Andrejević, S., Pavlović, M., Dimcic, Z., Ivanović, B., & Nikolic, M. M. (2010) · Clinical Rheumatology · doi:10.1007/s10067-010-1424-4 · Cited by 102
“The extracellular DNA, modified by antimicrobial proteins, can activate plasmacytoid dendritic cells to produce type 1 interferons via TLR9 [43].”
BackgroundMitochondrial DNA sensing by STING signaling participates in inflammation, cancer and beyond
Liu, S., Feng, M., & Guan, W. (2016) · International Journal of Cancer · doi:10.1002/ijc.30074 · Cited by 97
“In addition to IL-26-DNA complex, LL37 (an antimicrobial peptide derived from plasmacytoid dendritic cells) could also bind to self-DNA to activate IFN-a generation, and lead to uncontrollable immune events in autoimmune diseases.(26) Consistently, Collins et al.”
BackgroundNOD-like receptor signaling and inflammasome-related pathways are highlighted in psoriatic epidermis
Tervaniemi, M. H., Katayama, S., Skoog, T., Siitonen, H. A., Vuola, J., Nuutila, K., Sormunen, R. T., Johnsson, A., Linnarsson, S., Suomela, S., et al. (2016) · Scientific Reports · doi:10.1038/srep22745 · Cited by 101
New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis
Karczewski, J., Dobrowolska, A., Rychlewska-Hańczewska, A., & Adamski, Z. (2016) · Autoimmunity · doi:10.3109/08916934.2016.1166214 · Cited by 103
“Continuous overexpression of AMP LL37 observed in psoriatic skin [28,29] has been linked to both abnormal maturation of dendritic cells (DCs) and activation of T cells.”
BackgroundCathelicidins PMAP-36, LL-37 and CATH-2 are similar peptides with different modes of action
Scheenstra, M. R., van den Belt, M., Bokhoven, J. L. M. T.-V., Schneider, V. A. F., Ordoñez, S. R., van Dijk, A. I. J. M., Veldhuizen, E. J. A., & Haagsman, H. P. (2019) · Scientific Reports · doi:10.1038/s41598-019-41246-6 · Cited by 101
Antimicrobial Peptides in Innate Immune Responses
Sørensen, O. E., Borregaard, N., & Cole, A. M. (2008) · KARGER eBooks · doi:10.1159/000136315 · Cited by 115
Suárez‐Fariñas, M., Arbeit, R. D., Jiang, W., Ortenzio, F. S., Sullivan, T., & Krueger, J. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084634 · Cited by 98
“A positive feedback loop of inflammation is created when these pDCs and mDCs are activated by immune complexes consisting of self-nucleic acids and LL-37 (cathelicidin), an antimicrobial peptide overexpressed in psoriatic lesions [28], [29].”
BackgroundCoorens, M., Schneider, V. A. F., de Groot, A. M., van Dijk, A. I. J. M., Meijerink, M., Wells, J. M., Scheenstra, M. R., Veldhuizen, E. J. A., & Haagsman, H. P. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602164 · Cited by 97
“Second, cathelicidins have been shown to regulate activation of a wide variety of TLRs, including many mammalian TLRs, which can play an important role in the modulation of the inflammatory response during infections (24–29).”
Disease-Associated Plasmacytoid Dendritic Cells
Li, S., Wu, J., Zhu, S., Liu, Y.-J., & Chen, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01268 · Cited by 101
“These complexes are delivered to pDCs to trigger TLR-9 expression and local IFN-I production (109).”
BackgroundSelf-citationSusceptibility to Infectious Diseases Based on Antimicrobial Peptide Production
Rivas-Santiago, B. T., Serrano, C. J., & Enciso‐Moreno, J. A. (2009) · Infection and Immunity · doi:10.1128/iai.01515-08 · Cited by 97
“A recent study showed that LL-37 isolated from lesional skin forms complexes with human self-DNA to activate plasmacytoid dendritic cells (pDCs) (32).”
BackgroundZhu, Y., Mohapatra, S., & Weisshaar, J. C. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814924116 · Cited by 96
“How strong is the binding? A number of previous studies qualitatively demonstrate binding of LL-37 to dsDNA in vitro and in vivo (9, 15, 52, 53).”
BackgroundThe Human Antimicrobial Peptide LL-37 Suppresses Apoptosis in Keratinocytes
Chamorro, C. I., Weber, G., Grönberg, A., Pivarcsi, A., & Ståhle, M. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.321 · Cited by 106
“LL-37 is emerging as a key player in skin biology being implicated in wound healing (Heilborn et al., 2003; Shaykhiev et al., 2005; Carretero et al., 2008) and is overexpressed in psoriasis with a putative pathogenetic role in disease manifestation (Lande et al., 2007).”
BackgroundType1 Interferons Potential Initiating Factors Linking Skin Wounds With Psoriasis Pathogenesis
Zhang, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01440 · Cited by 102
“pDCs express high levels of TLR7 and TLR9, therefore pDC can rapidly sense self-DNA released upon injury then produce IFNα (13, 26, 39).”
BackgroundBrembilla, N. C., & Boehncke, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1186455 · Cited by 103
“A well-defined cascade starting with keratinocyte damage results in release of self-nucleic acids, which are subsequently complexed to antimicrobial peptides, and sensed by plasmacytoid dendritic cells (pDCs) (5).”
BackgroundInnate immunity in the pathogenesis of psoriasis
Sweeney, C. M., Tobin, A., & Kirby, B. (2011) · Archives of Dermatological Research · doi:10.1007/s00403-011-1169-1 · Cited by 109
“Activation of pDC results in the production of IFN-a which contributes to the pathogenesis of psoriasis [80].”
BackgroundFakher, F. H. A., Rachinel, N., Klimczak, M., Louis, J. A., & Doyen, N. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1386 · Cited by 92
Guiducci, C., Coffman, R. L., & Barrat, F. J. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02050.x · Cited by 109
Keratinocyte-Derived IL-17E Contributes to Inflammation in Psoriasis
Senra, L., Stalder, R., Martínez, D. Á., Chizzolini, C., Boehncke, W., & Brembilla, N. C. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.06.009 · Cited by 103
“A widely accepted hypothesis suggests that genetically predisposed individuals respond to environmental factors through an activation of dermal dendritic cells by a complex consisting of self DNA and the antimicrobial peptide LL-37 produced by keratinocytes (Lande et al., 2007).”
BackgroundJones, E. A., McGillivary, G., & Bakaletz, L. O. (2013) · Journal of Innate Immunity · doi:10.1159/000339961 · Cited by 91
Type I interferons in systemic autoimmunity
Sozzani, S., Bosisio, D., Scarsi, M., & Tincani, A. (2010) · Autoimmunity · doi:10.3109/08916930903510872 · Cited by 101
“Recent findings have disclosed the molecular mechanisms responsible for the production of IFN-I in certain autoimmune diseases, such as psoriasis (Ps), following the recognition of molecular complexes of the antimicrobial peptide LL37 with self-DNA and self-RNA [13,14].”
BackgroundThe Role of NLRP1, NLRP3, and AIM2 Inflammasomes in Psoriasis: Review
Ciążyńska, M. A., Olejniczak‐Staruch, I., Sobolewska-Sztychny, D., Narbutt, J., Skibińska, M., & Lesiak, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115898 · Cited by 96
“The extracellular self-DNA, which is normally removed via deoxyribonuclease (DNase), may aggregate with the antimicrobial cathelicidin peptide LL-37 and may activate psoriasis [44].”
BackgroundCathelicidin LL‐37: a defense molecule with a potential role in psoriasis pathogenesis
Dombrowski, Y., & Schauber, J. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01459.x · Cited by 97
An essential role for the N-terminal fragment of Toll-like receptor 9 in DNA sensing
Onji, M., Kanno, A., Saitoh, S.-I., Fukui, R., Motoi, Y., Shibata, T., Matsumoto, F., Lamichhane, A., Sato, S., Kiyono, H., et al. (2013) · Nature Communications · doi:10.1038/ncomms2949 · Cited by 89
Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation
Lai, C.-Y., Su, Y.-W., Lin, K.-I., Hsu, L.-C., & Chuang, T.-H. (2017) · Journal of Immunology Research · doi:10.1155/2017/7807313 · Cited by 88
Sensors of the innate immune system: their link to rheumatic diseases
Theofilopoulos, A. N., González‐Quintial, R., Lawson, B. R., Koh, Y. T., Stern, M. E., Kono, D. H., Beutler, B., & Baccalà, R. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.278 · Cited by 105
“DNA uptake, TLR9 engagement and IFN-α/β production by pDCs are also promoted by LL37, an antimicrobial cathelicidin peptide released following skin injury”
BackgroundChen, X., Takai, T., Xie, Y., Niyonsaba, F., Okumura, K., & Ogawa, H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.03.024 · Cited by 103
Coffelt, S. B., & Scandurro, A. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0044 · Cited by 88
“In psoriatic skin lesions, LL-37 is elevated in comparison with normal healthy skin, and the excessive proliferation and high turnover of keratinocytes results in an aberrantly high concentration of human DNA in the extracellular environment (17).”
Sebum lipids influence macrophage polarization and activation
Lovászi, M., Mattii, M., Eyerich, K., Gácsi, A., Csányi, E., Kovács, D., Rühl, R., Szegedi, A., Kemény, L., Ståhle, M., et al. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15754 · Cited by 88
Prinz, I., Sandrock, I., & Mrowietz, U. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20191397 · Cited by 91
“DCs, which subsequently activate dermal DCs via type I interferons (Lande et al., 2007).”
BackgroundThe Fatal Circle of NETs and NET-Associated DAMPs Contributing to Organ Dysfunction
Block, H., Rossaint, J., & Zarbock, A. (2022) · Cells · doi:10.3390/cells11121919 · Cited by 98
Wolfram, J. A., Diaconu, D., Hatala, D. A., Rastegar, J. C., Knutsen, D. A., Lowther, A., Askew, D. S., Gilliam, A. C., McCormick, T. S., & Ward, N. L. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080858 · Cited by 91
Chongsiriwatana, N. P., Lin, J. S., Kapoor, R., Wetzler, M., Rea, J. C., Didwania, M. K., Contag, C. H., & Barron, A. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-16180-0 · Cited by 89
Novoszel, P., Holcmann, M., Stulnig, G., Fernandes, C. D. S., Zyulina, V., Borek, I., Linder, M., Bogusch, A., Drobits, B., BAUER, T. L., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202012409 · Cited by 93
“However, host-derived ligands such as self-RNA/DNA can cause inappropriate activation of TLR7/9, triggering auto-immune diseases such as systemic lupus erythematosus (SLE) or psoriasis (Lande et al, 2007; Ganguly et al, 2009).”
Innate immune sensing of cell death in disease and therapeutics
Man, S. M., & Kanneganti, T. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01491-y · Cited by 100
“51) or the nuclear protein HMGB1 released by necrotic cells 52 .”
Turning NF-κB and IRFs on and off in DC
Kaisho, T., & Tanaka, T. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.03.005 · Cited by 96
Immune functions and recruitment of plasmacytoid dendritic cells in psoriasis
Albanesi, C., Scarponi, C., Bosisio, D., Sozzani, S., & Girolomoni, G. (2010) · Autoimmunity · doi:10.3109/08916930903510906 · Cited by 88
“LL-37 breaks innate tolerance to self-DNA by forming aggregated and condensed structures, which can trigger a robust induction of IFN-a via TLR9 activation [32].”
BackgroundJiang, W., Zhu, F., Bhagat, L., Yu, D. S., Tang, J. X., Kandimalla, E. R., Monica, N. L., & Agrawal, S. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.57 · Cited by 90
“Immune complexes formed by self-nucleic acids and LL-37, an antimicrobial peptide overexpressed in psoriatic lesions, activate both pDCs and myeloid DCs (Lande et al., 2007; Ganguly et al., 2009).”
BackgroundIdentification of Novel Autoantibodies Associated With Psoriatic Arthritis
Yuan, Y., Qiu, J., Lin, Z., Li, W., Haley, C. T., Mui, U. N., Ning, J., Tyring, S. K., & Wu, T. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40830 · Cited by 99
“LL37 is an antimicrobial peptide and overexpressed in psoriatic epidermis (32,55,56).”
BackgroundTargeting cell surface TLR7 for therapeutic intervention in autoimmune diseases
Kanno, A., Tanimura, N., Ishizaki, M., Ohko, K., Motoi, Y., Onji, M., Fukui, R., Shimozato, T., Yamamoto, K., Shibata, T., et al. (2015) · Nature Communications · doi:10.1038/ncomms7119 · Cited by 85
Autoreactive B Cells Discriminate CpG-Rich and CpG-Poor DNA and This Response Is Modulated by IFN-α
Uccellini, M. B., Busconi, L., Green, N. M., Busto, P., Christensen, S. R., Shlomchik, M. J., Marshak‐Rothstein, A., & Viglianti, G. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.5875 · Cited by 93
“Moreover, total mammalian DNA was reported to effectively activate a TLR9 fusion protein expressed on the surface of transfected HEK 293 cells (15), and total mammalian DNA complexed with the antimicrobial peptide LL37 was found to stimulate plasmacytoid dendritic cells (DCs) (16).”
BackgroundTillack, K., Naegele, M., Haueis, C., Schippling, S., Wandinger, K., Martinꝉ, R., & Sospedra, M. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.05.004 · Cited by 94
“The activation of DCs byNETs appears to play an important role in the pathogenesis of some autoimmune diseases such as psoriasis (Lande et al., 2007), systemic lupus erythematosus (SLE) (Barrat et al.”
BackgroundNeutrophils initiate and exacerbate Stevens-Johnson syndrome and toxic epidermal necrolysis
Kinoshita, M., Ogawa, Y., Hama, N., Ujiie, I., Hasegawa, A., Nakajima, S., Nomura, T., Adachi, J., Sato, T., Koizumi, S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aax2398 · Cited by 94
Severa, M., Diotti, R. A., Etna, M. P., Rizzo, F., Fiore, S., Ricci, D., Iannetta, M., Sinigaglia, A., Lodi, A., Mancini, N., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009878 · Cited by 92
“Furthermore, where indicated, PBMC and pDC were also pre-treated for 30 min with 1μM TLR7/8 antagonist, 2087c oligonucleotide (Miltenyi biotech) or with a control oligonucleotide sequence (ODN ctrl, 5-tcctgcaggttaagt-3, 1μM) [65] prior to stimulation with PLOS PATHOGENS Plasmacytoid dendritic cells and type I IFN in C…”
MethodUpdate on the etiopathogenesis of psoriasis (Review)
Branisteanu, D. E., Cojocaru, C., Diaconu, R., Porumb‐Andrese, E., Alexa, A. I., Nicolescu, A. C., Brihan, I., Bogdănici, C. M., Brănișteanu, G., Dimitriu, A., et al. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11124 · Cited by 108
From Empirical to Pathogenesis-Based Treatments for Psoriasis
van de Kerkhof, P. C. M. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.01.014 · Cited by 103
“KC proteins with similarity to streptococcal antigens (Besgen et al., 2010; Valdimarsson et al., 2009); 2. lipid antigens generated by PA24D: PA24D generated lipid antigen activates CD1a Langerhans cells, and these bind to CD1a-reactive T cells, which generate IL-17 and IL-22 (Cheung et al., 2016); 3. melanocyte autoa…”
BackgroundInfluentialCellular Mechanisms of Psoriasis Pathogenesis: A Systemic Review
Wu, M., Dai, C., & Zeng, F. (2023) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s420850 · Cited by 103
Etiology and Pathogenesis of Psoriatic Arthritis
Barnas, J. L., & Ritchlin, C. T. (2015) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.07.006 · Cited by 103
Antiviral Potential of Cathelicidins
Barlow, P. G., Findlay, E. G., Currie, S. M., & Davidson, D. J. (2013) · Future Microbiology · doi:10.2217/fmb.13.135 · Cited by 94
The many ways tissue phagocytes respond to dying cells
Blander, J. M. (2017) · Immunological Reviews · doi:10.1111/imr.12537 · Cited by 84
TLR9 is important for protection against intestinal damage and for intestinal repair
II, W. A. R., Sakamoto, K., & Leifer, C. A. (2012) · Scientific Reports · doi:10.1038/srep00574 · Cited by 84
IL-26 Confers Proinflammatory Properties to Extracellular DNA
Poli, C., Augusto, J., Dauvé, J., Adam, C., Preisser, L., Larochette, V., Pignon, P., Savina, A., Blanchard, S., Subra, J., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600594 · Cited by 96
“In psoriasis, LL37, secreted by activated keratinocytes, forms complexes with extracellular DNA and promotes TLR9-dependent pDCs and STINGdependent myeloid cell activation (13, 14).”
BackgroundLee, E. Y., Zhang, C., Domizio, J. D., Jin, F., Connell, W., Hung, M., Malkoff, N., Veksler, V., Gilliet, M. F., Ren, P. Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08868-w · Cited by 88
Self-citationPsoriasis and the TNF/IL23/IL17 axis
Furue, K., Ito, T., Tsuji, G., Kadono, T., & Furue, M. (2019) · Giornale Italiano di Dermatologia e Venereologia · doi:10.23736/s0392-0488.18.06202-8 · Cited by 82
Leszczyńska, K., Namiot, D. B., Byfield, F. J., Cruz, K., Żendzian‐Piotrowska, M., Fein, D. E., Savage, P. B., Diamond, S. L., McCulloch, C. A. G., Janmey, P. A., et al. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks434 · Cited by 84
Plasmacytoid dendritic cells and cancer
Vermi, W., Soncini, M., Melocchi, L., Sozzani, S., & Facchetti, F. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0411190 · Cited by 97
Update on the role of plasmacytoid dendritic cells in inflammatory/autoimmune skin diseases
Saadeh, D., Kurban, M., & Abbas, O. M. (2016) · Experimental Dermatology · doi:10.1111/exd.12957 · Cited by 94
“Recent studies have shown that in psoriatic skin, pDC activation occurs in response to extracellular self-DNA fragments that get coupled to the endogenous cationic antimicrobial peptides such as LL-37, beta-defensin (hBD)2, hBD3, and lysozyme that are overexpressed in psoriatic skin (107,108).”
BackgroundTeunissen, M. B. M., Haniffa, M. A., & Collin, M. P. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2011_169 · Cited by 98
“However, the human antimicrobial peptide LL37 can form a complex with self-RNA and self-DNA and thereby convert these otherwise inert nucleic acids into potent agonists for TLR7 and TLR9 (Lande et al. 2007; Ganguly et al. 2009).”
BackgroundRole of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases
Mackern‐Oberti, J. P., Llanos, C., Vega, F., Salazar‐Onfray, F., Riedel, C. A., Bueno, S. M., & Kalergis, A. M. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.10.010 · Cited by 94
“During psoriasis, a common immunemediated disease, LL-37 can be overexpressed and turns quiescent self-DNA into a potent IFN-α inducer by changing DNA structures and targeting this DAMP to early endocytic compartments, where it is recognized by TLR9 in pDCs [35] (Fig.”
BackgroundLimoli, D. H., Rockel, A. B., Host, K. M., Jha, A., Kopp, B. T., Hollis, T., & Wozniak, D. J. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004083 · Cited by 83
“Lande et al demonstrated that LL37 is capable of trafficking into dendritic cells, providing evidence that LL-37 can penetrate eukaryotic cells [46].”
BackgroundEffective and lesion-free cutaneous influenza vaccination
Wang, J., Li, B., & Wu, M. X. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500408112 · Cited by 87
“Because dsDNA not only takes central part in adjuvant effects, but also participates in other processes including wound healing (41), psoriasis (21), systemic lupus erythematosus (42), etc.”
BackgroundBeaumont, P. E., McHugh, B. J., Findlay, E. G., Mackellar, A., Mackenzie, K. J., Gallo, R. L., Govan, J. R. W., Simpson, A. J., & Davidson, D. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099029 · Cited by 94
“However, cathelicidins have additionally been shown to have multiple modulatory activities, including chemotactic function [34,35,36,37,38], the ability to modulate chemokine, cytokine and cellular responses [30,41,42,43], the capacity to alter leukocyte differentiation and function [44,45,46] and cell death modulatin…”
BackgroundPlasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation
Chistiakov, D. A., Orekhov, A. N., Sobenin, I. A., & Bobryshev, Y. V. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00279 · Cited by 111
Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury
Bei, Y., Pan, L., Zhou, Q., Zhao, C., Xie, Y., Wu, C., Meng, X., Gu, H., Xu, J., Zhou, L., et al. (2019) · BMC Medicine · doi:10.1186/s12916-019-1268-y · Cited by 87
Hurtado, P. R., & Peh, C. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902305 · Cited by 102
“(19) showed that LL-37 rendered human DNA capable of stimulating pDCs via TLR9.”
BackgroundInfluentialNeutrophil migration into the placenta: Good, bad or deadly?
Giaglis, S., Stoikou, M., Grimolizzi, F., Subramanian, B. Y., van Breda, S. V., Hoesli, I. M., Lapaire, O., Hasler, P., Than, N. G., & Hahn, S. (2016) · Cell Adhesion & Migration · doi:10.1080/19336918.2016.1148866 · Cited by 86
“of extracellular DNA into adjacent cells, where it can lead to the activation of the Toll-like receptor (TLR) system and consequent production of inflammatory cytokines such as interferon-a (IFN-a).(4) Such a mechanism has been proposed to occur in psoriasis.”
Unmet Needs in the Field of Psoriasis: Pathogenesis and Treatment
Boehncke, W., & Brembilla, N. C. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8634-3 · Cited by 93
Liang, H., Yan, Y., Wu, J., Ge, X., Wei, L., Liu, L., & Chen, Y. (2020) · Science Advances · doi:10.1126/sciadv.abb5274 · Cited by 82
Innate Immune Mechanisms to Protect Against Infection at the Human Decidual-Placental Interface
Hoo, R., Nakimuli, A., & Vento‐Tormo, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02070 · Cited by 90
“In addition to direct killing of pathogens, AMPs can rapidly modulate innate host immune responses by recruiting myeloid cells and lymphocytes to the site of infection and mediating activation of TLR (110, 111).”
BackgroundLo, Y., Torii, K., Saito, C., Furuhashi, T., Maeda, A., & Morita, A. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.03.018 · Cited by 82
The pathogenesis of psoriatic arthritis and associated nail disease: not autoimmune after all?
McGonagle, D., Benjamin, M., & Tan, A. L. (2009) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32832c6ab9 · Cited by 96
Takahashi, T., Kulkarni, N. N., Lee, E. Y., Zhang, L., Wong, G. C. L., & Gallo, R. L. (2018) · Scientific Reports · doi:10.1038/s41598-018-22409-3 · Cited by 84
Furue, K., Ito, T., & Furue, M. (2018) · Cytokine · doi:10.1016/j.cyto.2018.08.025 · Cited by 85
The Infectious Basis of ACPA-Positive Rheumatoid Arthritis
Sakkas, L. I., Daoussis, D., Liossis, S. C., & Bogdanos, D. P. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01853 · Cited by 86
“Also, LL37 can form complexes with DNA and RNA and stimulate innate TLRs (Lande et al., 2007; Ganguly et al., 2009).”
BackgroundAdvances in Toll-like receptor biology: Modes of activation by diverse stimuli
Bryant, C. E., Gay, N. J., Heymans, S. R. B., Sacre, S. M., Schaefer, L., & Midwood, K. S. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1033511 · Cited by 99
“However, in certain situations extracellular host DNA and RNA can become stabilized by binding to proteins such as the cathelicidin LL-37 or by forming an immune complex as is seen in the autoimmune disease SLE (Ganguly et al., 2009; Lande et al., 2007).”
BackgroundTomasello, E., Pollet, É., Manh, T. V., Uzé, G., & Dalod, M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00526 · Cited by 94
“Indeed, in psoriatic skin, both a high expression of LL37 and a massive infiltration of pDCs is observed (124) (Figure 4).”
BackgroundLAVERNY, G., Penna, G., Vetrano, S., Correale, C., Nebuloni, M., Danese, S., & Adorini, L. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.03.006 · Cited by 89
Ying, X., Chen, Q., Yang, Y., Wu, Z., Zeng, W., Miao, C., Huang, Q., & Ai, K. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02186-6 · Cited by 94
Hirai, M., Kadowaki, N., Kitawaki, T., Fujita, H., Takaori‐Kondo, A., Fukui, R., Miyake, K., Maeda, T., Kamihira, S., Miyachi, Y., et al. (2010) · Blood · doi:10.1182/blood-2010-05-284737 · Cited by 88
Kindrachuk, J., Jenssen, H., Elliott, M. R., Townsend, R., Nijnik, A., Lee, S. F., Gerdts, V., Babiuk, L. A., Halperin, S. A., & Hancock, R. E. W. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.094 · Cited by 80
Reithmayer, K., Meyer, K. C., Kleditzsch, P., Tiede, S., Uppalapati, S. K., Gläser, R., Harder, J., Schröder, J., & Paus, R. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09154.x · Cited by 81
Self-citationGungor, B., Yağcı, F. C., Tincer, G., Bayyurt, B., Alpdundar, E., Yildiz, S., Özcan, M., Gürsel, İ., & Gürsel, M. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007909 · Cited by 79
Metadata
- Authors
- Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., Zal, T., Mellman, I., Schröder, J.-M., Liu, Y.-J., & Gilliet, M.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Genentech (US)
- Heinrich Heine University Düsseldorf (DE)
- King's College London (GB)
- Christian-Albrechts-Universität zu Kiel (DE)
- Corresponding author
- Gilliet, Michel
- ORCID
- Venue
- Nature
- Published
- 2007-09-16
- Volume
- 449
- Issue
- 7162
- Pages
- 564-569
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2084951281
- Cited by
- 1,910
- References
- 43
- Citations by year
- 2026: 54 · 2025: 61 · 2024: 87 · 2023: 81 · 2022: 94 · 2021: 93 · 2020: 89 · 2019: 97 · 2018: 92 · 2017: 118 · 2016: 105 · 2015: 81 · 2014: 113 · 2013: 120 · 2012: 181
- FWCI
- 38.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI074809)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- plasmacytoid dendritic cells, LL-37, antimicrobial peptides, self-DNA, TLR9, type I interferon, psoriasis, autoimmunity, innate immune tolerance, vaccine adjuvants, skin inflammation
- MeSH terms
- Autoantigens, Autoimmune Diseases, Dendritic Cells, DNA, Endocytosis, Humans, Psoriasis, Endosomes, Autoimmunity, Antimicrobial Cationic Peptides, Toll-Like Receptor 9, Cathelicidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.